Yourgene Health PLC (LON:YGEN)’s share price traded down 1.5% on Thursday . The stock traded as low as GBX 10.59 ($0.14) and last traded at GBX 10.59 ($0.14), 173,283 shares changed hands during mid-day trading. The stock had previously closed at GBX 10.75 ($0.14).
The company has a market cap of $64.39 million and a P/E ratio of 11.94. The company has a debt-to-equity ratio of 2.67, a quick ratio of 0.94 and a current ratio of 1.25. The firm’s fifty day moving average is GBX 11.78 and its two-hundred day moving average is GBX 11.96.
In related news, insider Hayden Jeffreys bought 83,512 shares of Yourgene Health stock in a transaction on Wednesday, July 31st. The shares were purchased at an average price of GBX 12 ($0.16) per share, for a total transaction of £10,021.44 ($13,094.79). Also, insider Adam Reynolds bought 900,000 shares of Yourgene Health stock in a transaction on Friday, May 31st. The shares were bought at an average price of GBX 11 ($0.14) per share, for a total transaction of £99,000 ($129,361.03).
Yourgene Health Plc, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.
Read More: Bear Market – How and Why They Occur
Receive News & Ratings for Yourgene Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yourgene Health and related companies with MarketBeat.com's FREE daily email newsletter.